These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25332257)

  • 1. MELD exception for liver transplantation in portopulmonary hypertension: current implementation and future considerations.
    Porres-Aguilar M; Bartolome SD; Duarte-Rojo A
    Ann Hepatol; 2014; 13(6):719-21. PubMed ID: 25332257
    [No Abstract]   [Full Text] [Related]  

  • 2. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
    Krowka MJ; Fallon MB; Mulligan DC; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S114-6. PubMed ID: 17123283
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
    Krowka MJ; Wiesner RH; Heimbach JK
    J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel role of midodrine in pulmonary hypertension in liver transplant candidates.
    Rajaram P; Spivey J; Fisher M
    Liver Transpl; 2016 Jul; 22(7):1034-6. PubMed ID: 27090347
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.
    Salgia RJ; Goodrich NP; Simpson H; Merion RM; Sharma P
    Dig Dis Sci; 2014 Aug; 59(8):1976-82. PubMed ID: 24557576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.
    Mandell MS
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S54-8. PubMed ID: 15382220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
    DuBrock HM; Del Valle KT; Krowka MJ
    Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: liver transplantation for the pulmonary disorders of portal hypertension.
    Houlihan DD; Holt A; Elliot C; Ferguson JW
    Aliment Pharmacol Ther; 2013 Jan; 37(2):183-94. PubMed ID: 23146100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes.
    Rajoriya N; Tripathi D; Leithead JA; Gunson BK; Lord S; Ferguson JW; Hirschfield GM
    World J Gastroenterol; 2016 Dec; 22(45):9966-9973. PubMed ID: 28018103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M; Gitto S; Biselli M
    J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
    Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
    Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and pulmonary issues in LT assessment candidates.
    McAvoy NC; Hayes PC
    Clin Liver Dis; 2014 Aug; 18(3):529-41. PubMed ID: 25017074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for End-Stage Liver Disease-Sodium Score: The Evolution in the Prioritization of Liver Transplantation.
    Machicao VI
    Clin Liver Dis; 2017 May; 21(2):275-287. PubMed ID: 28364813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience.
    Rajaram P; Parekh A; Fisher M; Kempker J; Subramanian R
    Transplant Proc; 2017 Mar; 49(2):338-343. PubMed ID: 28219595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-lung versus liver transplantation for the treatment of portopulmonary hypertension--a comparison of two patients.
    Yoshida EM; Erb SR; Pflugfelder PW; Ostrow DN; Ricci DR; Ghent CN; Wall WJ; Grant D; Scudamore CH; Shackleton CB
    Transplantation; 1993 Mar; 55(3):688-90. PubMed ID: 8456497
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care.
    Sundaram SS; Mack CL; Feldman AG; Sokol RJ
    Liver Transpl; 2017 Jan; 23(1):96-109. PubMed ID: 27650268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
    Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
    Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.